Aspire Biopharma Warrant
ASBPW
26 hedge funds and large institutions have $624K invested in Aspire Biopharma Warrant in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 4 closing their positions.
3% more capital invested
Capital invested by funds: $604K → $624K (+$20.2K)
13% less funds holding
Funds holding: 30 → 26 (-4)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$3.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$1.97K |
| 2 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$888 |
| 3 |
Walleye Trading
New York
|
-$354 |
| 4 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$169 |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$57 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MTCM
26
Mint Tower Capital Management
Amsterdam,
Netherlands
| $1K | – | – | – |
|
|
27
Walleye Trading
New York
| $621 | -$354 | -13,114 | -50% |
|
|
28
Walleye Capital
New York
| – | -$1.97K | -46,560 | Closed |
|
|
CAC
29
Cowen and Company
New York
| – | -$1.21K | -28,700 | Closed |
|
|
MC
30
Meteora Capital
Boca Raton,
Florida
| – | -$888 | -21,000 | Closed |
|
ASBPW Hedge Fund Activity: Q4 2024 in Review
26 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Aspire Biopharma Warrant (ASBPW) for Q4 2024, worth a combined $624K — up 3.3% from $604K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ASBPW and 1 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 0 added.
The largest buyer was LMR Partners, opening a new position worth an estimated $3.38K. The largest seller was Walleye Capital, exiting entirely with an estimated $1.97K sold.
- 26 institutional investors held Aspire Biopharma Warrant (ASBPW) as of Q4 2024, down from 30 in Q3 2024.
- Funds reported $624K of Aspire Biopharma Warrant stock for Q4 2024, up 3.3% quarter-over-quarter.
- 1 fund opened new Aspire Biopharma Warrant positions in Q4 2024 and 4 closed out, a net change of -3 holders.
- The largest Aspire Biopharma Warrant buyer in Q4 2024 was LMR Partners, an estimated $3.38K added.
- The largest Aspire Biopharma Warrant seller in Q4 2024 was Walleye Capital, an estimated $1.97K sold.
Based on aggregated 13F filings for Q4 2024.